As urine-based tests are also applied for other urological malignancies including renal cell carcinoma (RCC), and upper tract urothelial carcinomas (UTUC), it is important to ascertain whether TERT promoter mutations are specific to BC only or widely present in different urological malignancies. Here, TERT is linked to hereditary clear cell renal cell carcinoma.